NEW YORK (GenomeWeb News) - Cyntellect said today it has received a Phase II Small Business Innovative Research grant from the National Cancer Institute worth $1.3 million to develop applications for its LEAP cell-imaging system.
 
LEAP (Laser-Enabled Analysis and Processing) is designed for high-throughput cell imaging and laser-based cell manipulation, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.